Dual risk stratification for dual antiplatelet therapy: SYNTAX and CHA2DS2-VASc score
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference5 articles.
1. The optimal discontinuation of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention with drug-eluting stents: a meta-analysis of randomized trials;Wang;Int J Cardiol.,2017
2. Validation of residual SYNTAX score with second-generation drug-eluting stents: one-year results from the prospective multicentre SEEDS study;Xu;EuroIntervention,2014
3. Impact of Six Versus 12Months of Dual Antiplatelet Therapy in Patients with Drug-eluting Stent Implantation After Risk Stratification with the Residual SYNTAX Score: Results from a Secondary Analysis of the I-LOVE-IT 2 Trial;Qiu,2017
4. The CHADS2 score is a useful predictor of coronary arteriosclerosis on 320 slice CT and may correlate with prognosis in subjects with atrial fibrillation;Uehara;Int. J. Cardiol.,2015
5. CHA2DS2-VASc score is a predictor of no-reflow in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous intervention;Ipek;Angiology,2015
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Association between subclinical hypothyroidism and coronary artery disease;PROG NUTR;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3